rotavirus

GSK's rotavirus shot runs short due to manufacturing issues

GSK faces an "unplanned, short-term drop in Rotarix production for 2022," thanks to unspecified "manufacturing challenges," the company told Fierce.

Fraiser Kansteiner Aug 11, 2022 4:00pm

Bharat Biotech picks up WHO prequalification for Rotavac

Jan 30, 2018 10:55am

Serum’s heat-stable rotavirus vaccine shines in phase 3

Mar 28, 2017 2:07pm